orsiro myocardial infarctio trial | Final 5‐Year Report of the Rando

Keyword	CPC	PCC	Volume	Score	Length of keyword
orsiro myocardial infarctio trial	1.04	0.7	3549	77	33
orsiro	1.73	0.2	6698	42	6
myocardial	1.8	0.5	3670	62	10
infarctio	1.38	0.5	4211	13	9
trial	0.76	0.5	3515	95	5

Keyword	CPC	PCC	Volume	Score
orsiro myocardial infarctio trial	0.35	0.8	5509	2

Search Results related to orsiro myocardial infarctio trial on Search Engine

Final 5‐Year Report of the Randomized BIO‐RESORT …
ahajournals.org

https://www.ahajournals.org/doi/full/10.1161/JAHA.122.026041

WEBNov 8, 2022 · The BIOSCIENCE trial found a higher mortality for Orsiro SES than for Xience EES (14.1% versus 10.3%), but that difference was driven by cancer‐related mortality. 6 In addition, in a diabetes substudy of BIOSCIENCE (n=486) the mortality …

DA: 28 PA: 69 MOZ Rank: 52

Acute myocardial infarction treated with novel Resolute …
wiley.com

https://onlinelibrary.wiley.com/doi/10.1002/ccd.29594

WEBMar 10, 2021 · Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial - Ploumen - 2021 - Catheterization and … Author: Eline Hubertina Ploumen, Eline Hubertina Ploumen, Rosaly Anne Buiten, Rosaly Anne Buiten, Paolo Zocc... Publish Year: 2021

Author: Eline Hubertina Ploumen, Eline Hubertina Ploumen, Rosaly Anne Buiten, Rosaly Anne Buiten, Paolo Zocc...
Publish Year: 2021

DA: 34 PA: 36 MOZ Rank: 89

Final 5‐Year Report of the Randomized BIO‐RESORT Trial
ahajournals.org

https://www.ahajournals.org/doi/full/10.1161/JAHA.122.026041

DA: 58 PA: 73 MOZ Rank: 87

Clinical outcomes of an ultrathin-strut sirolimus-eluting …
biomedcentral.com

https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-021-02310-0

WEBOct 16, 2021 · The Thailand Orsiro registry was a prospective, open-label clinical study evaluating all patients with obstructive coronary artery disease implanted with Orsiro … Author: Pannipa Suwannasom, Siriporn Athiksakul, Tasalak Thonghong, Vorarit Lertsuwunseri, Jarkarpun Chaipro... Publish Year: 2021

Author: Pannipa Suwannasom, Siriporn Athiksakul, Tasalak Thonghong, Vorarit Lertsuwunseri, Jarkarpun Chaipro...
Publish Year: 2021

DA: 27 PA: 91 MOZ Rank: 25

FULL COHORT | Orsiro
orsiro.com

https://en.orsiro.com/bioflow-v/full-cohort

WEBOrsiro and Orsiro Mission are indicated for improving coronary luminal diameter in patients, including those with diabetes mellitus, with symptomatic heart disease, stable angina, unstable angina, non-ST …

DA: 81 PA: 10 MOZ Rank: 79

Final 5‐Year Report of the Randomized BIO‐RESORT …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750072/

WEBNov 11, 2022 · Five years after PCI, both the novel Orsiro SES and Synergy EES showed no significant difference in the main end point TVF as compared with the Resolute …

DA: 9 PA: 37 MOZ Rank: 61

Acute myocardial infarction treated with novel Resolute …
researchgate.net

https://www.researchgate.net/publication/349970159_Acute_myocardial_infarction_treated_with_novel_Resolute_Onyx_and_Orsiro_stents_in_the_randomized_BIONYX_trial

WEBMar 10, 2021 · Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial. March 2021. Catheterization and Cardiovascular …

DA: 37 PA: 75 MOZ Rank: 92

FDA Approval and First Implant of Orsiro Mission Drug-Eluting
ptca.org

http://www.ptca.org/news/2021/0930_BIOTRONIK_ORSIRO.html

WEBBIOFLOW-V three-year study results with 1,334 patients shows that Orsiro DES offers a 40% lower target lesion failure rate (TLF) than Abbott’s Xience DES, 46% lower target …

DA: 51 PA: 33 MOZ Rank: 86

BIONYX Trial: Resolute Onyx vs. Orsiro DES in All …
acc.org

https://www.acc.org/latest-in-cardiology/journal-scans/2018/09/22/14/33/thin-composite-wire-strut-durable-bionyx-tct-2018

WEBLancet 2018;Sep 22: [Epub ahead of print]. Summary By: Debabrata Mukherjee, MD, FACC. Study Questions: What is the safety and efficacy of the Resolute Onyx stent …

DA: 31 PA: 64 MOZ Rank: 70